Massachusetts Legislature Proposes Banning Use Of Cost-Effectiveness Analysis To Inform Healthcare Coverage Decisions

The US healthcare system rations based on a person's ability to pay, quality of health insurance, and health status. Allowing for clinical- and cost-effectiveness considerations to inform allocation decisions is less arbitrary. Yet, Massachusetts lawmakers want to ban use of such considerations.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Decision Maker Content decisionmaker business pharma & Source Type: news